HLN1 N logo

Haleon plcBMV:HLN1 N Stock Report

Market Cap Mex$692.9b
Share Price
n/a
1Yn/a
7D0%
1D-3.9%
Portfolio Value
​
View

Haleon plc

BMV:HLN1 N Stock Report

Market Cap: Mex$692.9b

Haleon (HLN1 N) Stock Overview

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. More details

HLN1 N fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance4/6
Financial Health2/6
Dividends2/6

Rewards

Trading at 31.7% below our estimate of its fair value

Earnings have grown 5% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Has a high level of debt


HLN1 N Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW427,144 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
427,144 investors already sharing narratives
View all narratives

Haleon plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Haleon
Historical stock prices
Current Share PriceUK£171.00
52 Week HighUK£190.16
52 Week LowUK£159.85
Beta0.25
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change23.91%
5 Year Changen/a
Change since IPO13.79%

Recent News & Updates

Recent updates

Shareholder Returns

HLN1 NMX PharmaceuticalsMX Market
7D0%2.9%-0.9%
1Yn/a-8.8%5.3%

Return vs Industry: Insufficient data to determine how HLN1 N performed against the MX Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how HLN1 N performed against the MX Market.

Price Volatility

Is HLN1 N's price volatile compared to industry and market?
HLN1 N volatility
HLN1 N Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement3.3%
10% most volatile stocks in MX Market5.5%
10% least volatile stocks in MX Market2.3%

Stable Share Price: HLN1 N's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine HLN1 N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
171524,535Brian McNamarawww.haleon.com

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

Haleon plc Fundamentals Summary

How do Haleon's earnings and revenue compare to its market cap?
HLN1 N fundamental statistics
Market capMex$692.86b
Earnings (TTM)Mex$37.47b
Revenue (TTM)Mex$257.46b
18.5x
P/E Ratio
2.7x
P/S Ratio

Is HLN1 N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLN1 N income statement (TTM)
RevenueUK£11.15b
Cost of RevenueUK£3.84b
Gross ProfitUK£7.31b
Other ExpensesUK£5.69b
EarningsUK£1.62b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.18
Gross Margin65.57%
Net Profit Margin14.55%
Debt/Equity Ratio49.2%

How did HLN1 N perform over the long term?

See historical performance and comparison

Dividends

2.1%
Current Dividend Yield
40%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/19 03:59
End of Day Share Price 2026/08/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Haleon plc is covered by 26 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iain SimpsonBarclays
Warren AckermanBarclays
Bethan DaviesBerenberg